Treatment algorithm for opioid use disorder.

Slides:



Advertisements
Similar presentations
Co-Occurring Service Array Psychiatric Evaluation Medication Monitoring Clinical Consultation Family Therapy Individual Therapy / Individual Therapy-Crisis.
Advertisements

Attention deficit hyperactivity disorder Implementing NICE guidance 2008 NICE clinical guideline 72.
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
13 Principles of Effective Addictions Treatment
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
Background Problem alcohol use is a significant health issue, particularly among ‘high- risk’ populations (e.g. people treated for dependence on illicit.
SUD Module C: Care Management. or……. How to not cure anyone & still accomplish something & go home happy.
DMAS Office of Behavioral Health
Buprenorphine Treatment: Care Coordination Indications and Options James Schuster, MD, MBA Chief Medical Officer Community Care.
I n t e g r i t y - S e r v i c e - E x c e l l e n c e Headquarters U.S. Air Force 1 Primary Care Screening for Alcohol Misuse & Alcohol Use Disorders.
Chapter 8 Depression and Human Immunodeficiency Virus Francine Cournos, MD Karen McKinnon, MA Mark Bradley, MD Copyright © World Psychiatric Association.
Sublingual Buprenorphine and Pain
© 2006 McGraw-Hill Higher Education. All rights reserved. Chapter 18 Treating Substance Abuse and Dependence.
Alcohol Interventions: What the research tells us Professor Colin Drummond.
Referral to Treatment Referral.
Can We Meet the Challenge? Raymond Tallis FRCP FMedSci SIG Meeting1.
Sarah E. Cavanaugh Addiction Therapy-2014 Chicago, USA August 4 - 6, 2014.
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
The Diagnostic and Statistical Manual of Mental Disorders.
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
ADOLESCENTS IN CRISIS: WHEN TO ADMIT FOR SELF-HARM OR AGGRESSIVE BEHAVIOR Kristin Calvert.
Services Overview: Mental Health/Substance Use Disorders Programs and Managed Care Plans 1 Medi-Cal Managed Care Plans (MCP) County Mental Health Plan.
Provider Toolkit Products Key Points - single page bullet cards – Primary Care – Specialty Care Pocket Guide – Primary Care – Specialty Care – Pharmacotherapy.
SCREENING BRIEF INTERVENTION AND REFERRAL TO TREATMENT (SBIRT) 1.
Sudipta Sen 2 nd June 2015 INTEGRATED/COLLABORATIVE CARE IN ADHD MANAGEMENT.
CJ411-Seminar 8 What are the major treatment strategies currently used for drug and alcohol abuse?
November 4, Substance Use Disorders Consultation Service (SUDS): Integrating Addiction Services in an Acute Medical Setting Anika Alvanzo, MD, MS.
What Does Research Tell Us? Care Manager Roles in Depression Care.
Care Packages in Substance Misuse Treatment Development of MH Care Clusters: overview  Service users in MH, clinicians found: idiosyncratic referral pathways.
WESTCARE NEVADA Community Triage Center WestCare Nevada has been providing social model, non medical detoxification services to the community since 1989.
The Diagnostic and Statistical Manual of Mental Disorders.
TOWARDS RECOVERY CLINICS Patient Care. Community Fit. An Integrated Approach to Comprehensive Treatment.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Management of Substance Use Disorder Module P: Addiction-Focused Pharmacotherapy.
The CONTINUUM OF CARE Essential for Effective Substance Use Disorder Prevention, Treatment & Recovery Support Services.
H Department of Medical Assistance Services Substance Abuse Day Treatment 2013.
What is Court Services ? If you represent clients who have been charged with a misdemeanor or felony and who may have substance abuse and/or mental health.
Treating generalised anxiety disorder in primary care – an example of a treatment pathway Step 3: review and consideration of alternative treatments Step.
Brief Intervention. Brief Intervention has a number of different definitions but usually encompasses: –assessment –provision of education, support and.
Specialist service provision. Who is involved in specialist services? Statutory services –Run by NHS and Social Care, these deliver medical and psychosocial.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
CHAPTER 4: Assessment, Diagnosis, and Treatment Planning Substance Abuse and Addiction Treatment: Practical Application of Counseling Theory First Edition.
CHAPTER 8: Group Treatment Substance Abuse Counseling: Theory and Practice Fifth Edition Patricia Stevens Robert L. Smith Prepared by: Dr. Susan Rose,
Virginia Summer Institute for Addiction Studies July 11, 2016 Malcolm V. King MS CSAC Child and Family Program Specialists Virginia Department of Behavioral.
Substance Exposed Newborns: Addressing Substance Use Disorder
FADAA Health Care Reform
MWCC.MS.GOV  Services  Medical Fee Schedule
Step 1: recognition and diagnosis Step 2: treatment in primary care
Mean scores for symptoms of mental illness between 1994/95 and 2004/05 in participants aged 10–11 years (A), between 1996/97 and 2007/08 in those aged.
PCN 501 Competitive Success-- snaptutorial.com
PCN 501 Education for Service-- snaptutorial.com
PCN 501 Teaching Effectively-- snaptutorial.com
PCN 501 knowledge is divine-- snaptutorial.com. PCN 501 Week 1 Assignment Comparison of Theories Paper For more classes visit Comparison.
Opioid Prescribing & Monitoring
Treating Alcohol Abuse
Management of Substance Use Disorders
The Patient Journey to Remission in MDD: A Collaborative Approach
The Comprehensive Major Depressive Disorder Care Team
Treatment of Clients Experiencing Anxiety
Clinical Intake Assessment
DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Office of Aerospace. Medicine
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Classification and Treatment Plans
Medication Assisted Treatment of Opioid Use Disorder
Baseline characteristics of people who inject drugs enrolled in the Montreal Hepatitis C Cohort (2004–2017), by prescribed dosage of opioid agonist treatment,
Hazard ratios for associations between incident hepatitis C virus infection and prescribed dosage of opioid agonist treatment, categorized according to.
Presentation transcript:

Treatment algorithm for opioid use disorder. Treatment algorithm for opioid use disorder. Note: A particular medication may not be indicated for a variety of reasons, including ineffectiveness or medical contraindication, comorbidities, drug–drug interactions, patient preference and specific circumstances, and prescriber’s experience. Any treatment for opioid use disorder, but particularly slow agonist tapers, should incorporate evidence-based psychosocial interventions with qualified professionals, motivational interviewing, long-term monitoring of substance use, provision of comprehensive primary care, and referrals to psychosocial treatment interventions and psychosocial supports as appropriate, with specialist care as required, to optimize physical and mental wellness as the patient progresses in recovery. Withdrawal management (formerly “detoxification”) without linkage to long-term addiction treatment is to be avoided, and patients desiring such approach should be informed of risks and encouraged toward other treatment options that would suit their circumstances. DSM-5 = Diagnostic and Statistical Manual of Mental Disorders, fifth edition.74 Julie Bruneau et al. CMAJ 2018;190:E247-E257 ©2018 by Canadian Medical Association